Voleon Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Buy
+2,292
New +$1.47M 0.03% 401
2025
Q4
Sell
-1,099
Closed -$702K 900
2025
Q3
$702K Buy
1,099
+475
+76% +$288K 0.02% 510
2025
Q2
$335K Sell
624
-2,308
-79% -$1.1M 0.02% 385
2025
Q1
$1.23M Sell
2,932
-5,371
-65% -$2.33M 0.1% 178
2024
Q4
$3.43M Buy
+8,303
New +$3.64M 0.25% 101
2021
Q1
Sell
-12,000
Closed -$6M 17
2020
Q4
$6M Buy
+12,000
New +$5.37M 0.64% 38
2019
Q3
Sell
-1,000
Closed -$275K 190
2019
Q2
$275K Buy
+1,000
New +$246K 0.02% 173

Other funds holding IDXX

Voleon Capital Management's IDXX Position: Q1 2026 in Review

Voleon Capital Management opened a new position in Idexx Laboratories (IDXX) in Q1 2026: 2,292 shares worth $1.29M. The stake represents 0.03% of the portfolio and ranks #401 among its holdings. This is a return to the name: Voleon Capital Management previously reported a position in IDXX as recently as Q3 2025.

Voleon Capital Management first reported a position in IDXX in Q2 2019 and has held it in 7 quarters since. The position peaked at $6M in Q4 2020. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Voleon Capital Management held 2,292 shares of Idexx Laboratories worth $1.29M as of Q1 2026.
  • Idexx Laboratories was a new Voleon Capital Management position in Q1 2026.
  • Idexx Laboratories made up 0.03% of Voleon Capital Management's portfolio in Q1 2026, its #401 holding.
  • Voleon Capital Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 7 quarters since.
  • Voleon Capital Management's Idexx Laboratories position peaked at $6M in Q4 2020.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.